MARY RIVERA: Open Payments
NPI 1720731169 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,415 in 135 payments from 17 companies in 2025. Trend: 2023 $432 · 2024 $2,425 · 2025 $2,415
Food & beverage: $2,415
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $512 |
| AstraZeneca Pharmaceuticals LP | 16 | $308 |
| Exact Sciences Corporation | 10 | $233 |
| GlaxoSmithKline, LLC. | 17 | $233 |
| Neurocrine BioSciences, Inc. | 6 | $209 |
| PFIZER INC. | 9 | $156 |
| Lilly USA, LLC | 10 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $107 |
| Amgen Inc. | 5 | $93 |
| Phathom Pharmaceuticals, Inc. | 10 | $91 |
Products named: VRAYLAR, INGREZZA, BREZTRI, TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, The Cologuard Plus Collection Kit, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
